Anti-glomerular basement membrane disease

Journal of the American Society of Nephrology

Volumn 10, Issue 11, 1999, Pages 2446-2453

  Kluth, David C ^a   Rees, Andrew J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; FRESH FROZEN PLASMA; HUMAN ALBUMIN; PREDNISOLONE;

ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC PREDISPOSITION; GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; KIDNEY BIOPSY; KIDNEY DISEASE; LUNG HEMORRHAGE; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; VASCULITIS;

EID: 0032711937     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v10112446     Document Type: Article

References (63)

1. Goodpasture EW: The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci 158: 863-870, 1919
2. Turner AN, Rees AJ: Antiglomerular basement membrane disease. In: Oxford Textbook of Nephrology, 2nd Ed., edited by Davison AM, Cameron JS, Grunfeld J-P, Kerr DNS, Ritz E, Winearls CG, Oxford University Press, 1998, pp 645-666
3. Wilson CB, Dixon FJ: Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 3: 74-89, 1973
4. Couser WG: Rapidly progressive glomerulonephritis: Classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 11: 449-464, 1988
5. Andrassy K, Kuster S, Waldherr R, Ritz E: Rapidly progressive glomerulonephritis: Analysis of prevalence and clinical course. Nephron 59: 206-212, 1991
6. Segelmark M, Butkowski R, Wieslander J: Antigen restriction and IgG subclasses among anti-GBM autoantibodies. Nephrol Dial Transplant 5: 991-996, 1990
7. Merkel F, Pullig O, Marx M, Netzer KO, Weber M: Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: Report of 35 cases. Nephrol Dial Transplant 9: 372-376, 1994
8. Simpson IJ, Doak PB, Williams LC, Blacklock HA, Hill RS, Teague CA, Herdson PB, Wilson CB: Plasma exchange in Goodpasture's syndrome. Am J Nephrol 2: 301-311, 1982
9. Perez GO, Bjornsson S, Ross AH, Aamato J, Rothfield N: A mini-epidemic of Goodpasture's syndrome clinical and immunological studies. Nephron 13: 161-173, 1974
10. Beirne GJ, Wagnild JP, Zimmerman SW, Macken PD, Burkholder PM: Idiopathic crescentic glomerulonephritis. Medicine 56: 349-381, 1977
11. Bombassei GJ, Kaplan AA: The association between hydrocarbon exposure and anti-glomerular basement membrane anybody-mediated disease (Goodpasture's syndrome). Am J Ind Med 21: 141-153, 1992
12. Guerin V, Rabian C, Noel LH, Droz D, Baron C, Lallemand F, Jungers: Anti-glomerular-basement-membrane disease after lithotripsy. Lancet 335: 856-857, 1990
13. Umekawa T, Kohri K, Iguchi M, Yoshioka K, Kurita T: Glomerular-basement-membrane antibody and extracorporeal shock wave lithotripsy. Lancet 341: 556, 1993
14. Xenocostas A, Jothy S, Collins B, Loertscher R, Levy M: Antiglomerular basement membrane glomerulonephritis after extracorporeal shock wave lithotripsy. Am J Kidney Dis 33: 128-132, 1999
15. Weber MF, Andrassy K, Pullig O, Koderisch J, Netzer K: Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis. J Am Soc Nephrol 2: 1227-1234, 1992
16. Donaghy M, Rees AJ: Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 2: 1390-1393, 1983
17. Klassen J, Elwood C, Grossberg AL, Milgrom F, Montes M, Sepulveda M, Andres GA: Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis. N Engl J Med 290: 1340-1344, 1974
18. Moorthy AV, Zimmerman SW, Burkholder PM, Harrington AR: Association of crescentic glomerulonephritis with membranous glomerulonephropathy: A report of three cases. Clin Nephrol 6: 319-325, 1976
19. Richman AV, Rifkin SI, McAllister CJ: Rapidly progressive glomerulonephritis: Combined antiglomerular basement membrane antibody and immune complex pathogenesis. Hum Pathol 12: 597-604, 1981
20. Kurki P, Helve T, von Bonsdorff M, Tornroth T, Pettersson E, Riska H, Miettinen A: Transformation of membranous glomerulonephritis into crescentic glomerulonephritis with glomerular basement membrane antibodies: Serial determinations of antiGBM before the transformation. Nephron 38: 134-137, 1984
21. Relman AS, Dvorak HF, Colvin RB: Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 46-1971. N Engl J Med 285: 1187-1196, 1971
22. Wahls TL, Bonsib SM, Schuster VL: Coexistent Wegener's granulomatosis and anti-glomerular basement membrane disease. Hum Pathol 18: 202-205, 1987
23. Jayne DR, Marshall PD, Jones SJ, Lockwood CM, Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 37: 965-970, 1990
24. Weber MF, Andrassy K, Pullig O, Koderisch J, Netzer K: Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis. J Am Soc Nephrol 2: 1227-1234, 1992
25. Bosch X, Mirapeix E, Font J, Borrellas X, Rodriguez R, Lopez-Soto A, Ingelmo M, Revert L: Prognostic implication of antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease, Clin Nephrol 36: 107-113, 1991
26. Phelps RG, Rees AJ: The HLA complex in Goodpasture's disease: A model for analysing genetic susceptibility to autoimmunity. Kidney Int 1999, in press
27. Phelps RG, Jones VL, Coughlan M, Turner AN, Rees AJ: Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. J Biol Chem 273: 11440-11447, 1998
28. Phelps RG, Turner AN, Rees AJ: Direct identification of naturally processed atitoantigen-derived peptides bound to HLA-DR15. J Biol Chem 271: 18549-18553, 1996
29. Kalluri R, Sun MJ, Hudson BG, Neilson EG: The Goodpasture autoantigen: Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen. J Biol Chem 271: 9062-9068, 1996
30. Ryan JJ, Mason PJ, Pusey CD, Turner N: Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition. Clin Exp Immunol 113: 17-27, 1998
31. Hellmark T, Segelmark M, Unger C, Burkhardt H, Saus J, Wieslander J: Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease. Kidney Int 55: 936-944, 1999
32. Lerner RA, Glassock RJ, Dixon FJ: The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 126: 989-1004, 1967
33. Lerner RA, Glassock RJ, Dixon FJ: The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Am Soc Nephrol 10: 1389-1404, 1999
34. Saxena R, Bygren P, Butkowski R, Wieslander J: Specificity of kidney-bound antibodies in Goodpasture's syndrome. Clin Exp Immunol 78: 31-36, 1989
35. Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM: Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J 292: 301-304, 1986
36. Derry CJ, Ross CN, Lombardi G, Mason PD, Rees AJ, Lechler RI, Pusey CD: Analysis of T cell responses to the autoantigen in Goodpasture's disease. Clin Exp Immunol 100: 262-268, 1995
37. Merkel F, Kalluri R, Marx M, Enders U, Stevanovic S, Giegerich G, Neilson EG, Rammensee HG, Hudson BG, Weber M: Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen. Kidney Int 49: 1127-1133, 1996
38. Nolasco FE, Cameron JS, Hartley B, Coelho A, Hildreth G, Reuben R: Intraglomerular T cells and monocytes in nephritis: Study with monoclonal antibodies. Kidney Int 31: 1160-1166, 1987
39. Herody M, Bobrie G, Gouarin C, Grunfeld JP, Noel LH: Anti-GBM disease: Predictive value of clinical, histological and serological data. Clin Nephrol 40: 249-255, 1993
40. Teague CA, Doak PB, Simpson IJ, Rainer SP, Herdson PB: Goodpasture's syndrome: An analysis of 29 cases. Kidney Int 13: 492-504, 1978
41. Briggs WA, Johnson JP, Teichman S, Yeager HC, Wilson CB: Antiglomerular basement membrane antibody-mediated glomerulonephritis and Goodpasture's syndrome. Medicine 58: 348-361, 1979
42. Ewan PW, Jones HA, Rhodes CG, Hughes JM: Detection of intrapulmonary hemorrhage with carbon monoxide uptake: Application in Goodpasture's syndrome. N Engl J Med 295: 1391-1396, 1976
43. Bowley NB, Hughes JM, Steiner RE, The chest X-ray in pulmonary capillary haemorrhage: Correlation with carbon monoxide uptake. Clin Radiol 30: 413-417, 1979
44. Border WA, Baehler RW, Bhathena D, Glassock RJ: IgA anti-basement membrane nephritis with pulmonary hemorrhage. Ann Intern Med 91: 21-25, 1979
45. Saxena R, Bygren P, Rasmussen N, Wieslander J: Circulating autoantibodies in patients with extracapillary glomerulonephritis. Nephrol Dial Transplant 6: 389-397, 1991
46. Johnson JP, Moore JJ, Austin HA, Balow JE, Antonovych TT, Wilson CB: Therapy of anti-glomerular basement membrane antibody disease: Analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine 64: 219-227, 1985
47. Flores JC, Taube D, Savage CO, Cameron JS, Lockwood CM, Williams DG, Ogg CS: Clinical and immunological evolution of oligoanuric anti-GBM nephritis treated by haemodialysis. Lancet 1: 5-8, 1986
48. Walker RG, Scheinkestel C, Becker GJ, Owen JE, Dowling JP, Kincaid-Smith P: Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome. Q J Med 54: 75-89, 1985
49. Cohen LH, Wilson CB, Freeman RM: Goodpasture syndrome: Recovery after severe renal insufficiency. Arch Intern Med 136: 835-837, 1976
50. Maxwell AP, Nelson WE, Hill CM: Reversal of renal failure in nephritis associated with antibody to glomerular basement membrane, Br Med J 297: 333-334, 1988
51. de Torrente A, Popovtzer MM, Guggenheim SJ, Schrier RW: Serious pulmonary hemorrhage, glomerulonephritis, and massive steroid therapy, Ann Intern Med 83: 218-219, 1975
52. Dahlberg PJ, Kurtz SB, Donadio JV, Holley KE, Velosa JA, Williams DE, Wilson CB: Recurrent Goodpasture's syndrome. Mayo Clin Proc 53: 533-537, 1978
53. Mehler PS, Brunvand MW, Hutt MP, Anderson RJ: Chronic recurrent Goodpasture's syndrome. Am J Med 82: 833-835, 1987
54. Hind CR, Bowman C, Winearls CG, Lockwood CM: Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange. Clin Nephrol 21: 244-246, 1984
55. Levy JB, Lachmann RH, Pusey CD: Recurrent Goodpasture's disease. Am J Kidney Dis 27: 573-578, 1996
56. Netzer KO, Merkel F, Weber M: Goodpasture syndrome and end-stage renal failure - to transplant or not to transplant? Nephrol Dial Transplant 13: 1346-1348, 1998
57. Peten E, Pirson Y, Cosyns JP, Squifflet JP, Alexandre GP, Noel LH, Grunfeld JP, van Ypersele D, Querin S, Droz D: Outcome of thirty patients with Alport's syndrome after renal transplantation. Linear glomerular IgG fixation in renal allografts: Incidence and significance in Alport's syndrome. Transplantation 52: 823-826, 1991
58. Querin S, Noel LH, Grunfeld JP, Droz D, Mahieu P, Berger J, Kreis H: Linear glomerular IgG fixation in renal allografts: Incidence and significance in Alport's syndrome. Clin Nephrol 25: 134-140, 1986
59. Rigden SP, Mehls O, Jones EH, Valderrabano F: Report on management of renale failure in Europe, XXVI, 1995. The child-adult interface: A report on Alport's syndrome. 1975-1993. The ERA-EDTA Registry. Nephrol Dial Transplant 11[Suppl 7]:21-27, 1996
60. Brainwood D, Kashtan C, Gubler MC, Turner AN: Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int 53: 762-766, 1998
61. Kalluri R, Weber M, Netzer KO, Sun MJ, Neilson EG, Hudson BG: COL4A5 gene deletion and production of post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 45: 721-726, 1994
62. Ding J, Zhou J, Tryggvason K, Kashtan CE: COL4A5 deletions in three patients with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 5: 161-168, 1994
63. Benoit FL, Rulon DB, Theil GB, Doolan PD, Watten RH: Goodpasture's syndrome: A clinicopathologic entity. Am J Med 58: 424-444, 1963